Résultats de la recherche

  • Flux RSS
(1 - 19 of 19)
Why and how to find neutraligands targeting chemokines?
Composition contenant au moins un inhibiteur de certaines chimiokines, son procédé d’obtention et son utilisation en dermocosmétique pharmaceutique
Inhibitors of the interaction between a protein belonging to GPRASP protein family and a protein belonging to GPCR protein family and their use as drugs
Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice
Les neutraligands à l'assaut des chimiokines
Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose
Identification of CCL17 neutraligands targeting atopic diseases
Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo
Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines
Un neutraligand de la chimiokine CXCL12 inhibe la fibroprolifération dans un modèle de bronchiolite oblitérante après transplantation hétérotopique de trachée chez la souris
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats
A strategy to discover decoy chemokine ligands with an anti-inflammatory activity
Deciphering of the mechanism of the anti-asthmatic action of the CXCL12 neutraligand, chalcone 4
Mannoside Glycolipid Conjugates Display Anti-inflammatory Activity by Inhibition of Toll-like Receptor-4 Mediated Cell Activation
Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
A bifunctional-biased mu-opioid agonist–neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects
Phenylpyridine-2-ylguanidines and rigid mimetics as novel inhibitors of TNFα overproduction: Beneficial action in models of neuropathic pain and of acute lung inflammation
Discovery and characterization of an endogenous CXCR4 antagonist

Islandora displays